Cardior Pharmaceuticals picks up $76m Series B

Cardior Pharmaceuticals, a developer of non-coding RNA-based therapeutics for patients with cardiac diseases, has raised $76 million in Series B financing.

Cardior Pharmaceuticals, a developer of non-coding RNA-based therapeutics for patients with cardiac diseases, has raised $76 million in Series B financing. Inkef Capital led the round with participation from other backers that included Fund+, Sunstone, Hadean Ventures and Coparion, LSP, BioMedPartners, Bristol Myers Squibb and High-Tech Gründerfonds.

Source: Press Release